undamentalytics Newsletter
Sign in

Pulse Biosciences, Inc. revenue

Pulse Biosciences, Inc.'s revenue was $350,000 in fiscal 2025. Since fiscal 2021 ($1.4m) it has grown at a compound -29.5% a year. Over the last twelve months it was $1.2m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue0110001
Growth on the year before——−50.6%−100.0%———
Gross profit0−1−1100−00

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Pulse Biosciences, Inc. $1.2m 100.0% —
Insight Molecular Diagnostics Inc. $1.7m -60.8% 14.9%
Seastar Medical Holding Corp $1.7m 123.6% —
Co-diagnostics, Inc. $721,387 -28.1% -53.8%
Femasys Inc $2.3m 21.9% 24.3%
Volitionrx LTD $2.5m 86.3% 68.0%

Compare with peers

Head to head: IMDX vs PLSEICU vs PLSECODX vs PLSE

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Pulse Biosciences, Inc.